 | The 131st Annual Meeting (November 15-19, 2003) of APHA |
|
| The 131st Annual Meeting (November 15-19, 2003) of APHA |
Robert W. Spaliatsos, MS1, Karin Rosenblatt, MPH, PhD2, and Megan H. Mustafoff1. (1) Community Health, University of Illinois at Urbana-Champaign, 120 Huff Hall, 1206 S. Fourth St., Champaign, IL 61820, (2) UIUC, 120 Huff Hall, 1206 S. Fourth Street, Champaign, IL 61820, 217-244-8131, krosenbl@uiuc.edu
Primary fallopian tube cancer is a relatively rare tumor of gynecologic cancer that may often be mistaken for ovarian cancer during initial operative diagnoses and/or during microscopic examination by a pathologist. A total of 1233 cases of primary malignant fallopian tube cancer were identified in the SEER (Surveillance Epidemiology and End Results) Registries between 1973 and 1999; these registries makeup approximately 11% of the U.S. population. Whites had an age adjusted rate of 2.34 per million as compared to blacks with a rate of 2.14 per million. Fallopian tube tumors were found to be increasing annually by 2.1% (CI=1.2, 3.0, p<0.05). When looking at the increase in terms of race, it was statistically significant only in whites at 2.2% (CI=1.3, 3.1, p<0.05). The rate of fallopian tube cancer in 1973 was 1.34 cases per million, whereas in 1999, the rate was 2.48 cases per million, however, the trend in increase over this period was 0.567% annually (CI=-0.209, 1.349, p<0.05)). In whites, however, there was a statistically significant increase in the trend in rate of the disease, which showed a 0.937% annual increase in rate (CI=0.122, 1.759, p<0.05). Looking at the disease frequency by age, women aged 65-69 and 70-74 showed statistically significant increases, with a 4.2% and 4.9% annual increase respectively (p<0.05). Overall increase may be due to better diagnosis or to an actual increase.
Learning Objectives:
Keywords: Cancer, Epidemiology
Presenting author's disclosure statement:
I do not have any significant financial interest/arrangement or affiliation with any organization/institution whose products or services are being discussed in this session.